Sage Journals: Discover world-class research

Retricted access

Research article

First published 2009-12

Lymphocytic Toxicity in Patients After Peptide-Receptor Radionuclide Therapy (PRRT) with 177 Lu-DOTATATE and 90 Y-DOTATOC

Maribel L. Sierra, Alberto Agazzi, Lisa Bodei [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2007-02

From Outside to Inside? Dose-Dependent Renal Tubular Damage After High-Dose Peptide Receptor Radionuclide Therapy in Rats Measured with In Vivo 99m Tc-DMSA-SPECT and Molecular Imaging

Flavio Forrer, Edgar Rolleman, Magda Bijster [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Editorial

First published 2010-10

Pretherapy Prediction of Nephrotoxicity After Peptide Radionuclide Receptor Therapy (PRRT)

Gerald L. DeNardo, Daniel J. Macey

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2008-12-1

Normative data and test-retest reliability of the sinusoidal harmonic acceleration test,pseudorandom rotation test and velocity step test

Leen Maes, Ingeborg Dhooge, Eddy De Vel [...]

Journal of Vestibular Research

Retricted access

Research article

First published 2004-04

Radiolabeled Carbohydrated Somatostatin Analogs: A Review of the Current Status

Hans-Jürgen Wester, Margret Schottelius, Thorsten Poethko [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2022

Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna

Philipp Melhorn, Elisabeth Kretschmer-Chott, Ladislaia Wolff [...]

Therapeutic Advances in Medical Oncology

Retricted access

Brief report

First published 2021-6

Severe metabolic acidosis and hyperkalemia after peptide receptor radionuclide therapy. A case report,review of the literature and proposed treatment algorithm

Nikolaos A Trikalinos, Hyun Kim, Amir Iravani [...]

Journal of Onco-Nephrology

Retricted access

Research article

First published 2022-04

Estimation of Absorbed Doses of Indigenously Produced “Direct-route” Lutetium-177-[ 177 Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [ 177 Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles

Kamaldeep, Gaurav Wanage, Sarvesh Loharkar [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2021-10

177 Lu-dotatate use in chronic kidney disease patients: A single center experience

Sandhya Manohar, Panagiotis Kompotiatis, Thorvardur R Halfdanarson [...]

Journal of Onco-Nephrology

Retricted access

Review article

First published 2015-03

Peptide Receptor Radionuclide Therapy: An Overview

Ashutosh Dash, Sudipta Chakraborty, Maroor Raghavan Ambikalmajan Pillai [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results